SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001367644-18-000023
Filing Date
2018-05-04
Accepted
2018-05-04 16:04:22
Documents
59
Period of Report
2018-03-31

Document Format Files

Seq Description Document Type Size
1 form10-q032018.htm 10-Q 832461
2 exhibit10_1.htm EX-10.1 40338
3 exhibit10_2.htm EX-10.2 90648
4 ex12.htm EX-12 59311
5 exhibit31_1.htm EX-31 12888
6 exhibit31_2.htm EX-31 12513
7 exhibit32_1.htm EX-32 3324
8 exhibit32_2.htm EX-32 3367
15 image00011.jpg GRAPHIC 6088
  Complete submission text file 0001367644-18-000023.txt   3591195

Data Files

Seq Description Document Type Size
9 XBRL INSTANCE DOCUMENT ebs-20180331.xml EX-101.INS 382853
10 XBRL TAXONOMY EXTENSION SCHEMA ebs-20180331.xsd EX-101.SCH 34518
11 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE ebs-20180331_cal.xml EX-101.CAL 69080
12 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE ebs-20180331_def.xml EX-101.DEF 147125
13 XBRL TAXONOMY EXTENSION LABEL LINKBASE ebs-20180331_lab.xml EX-101.LAB 495892
14 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE ebs-20180331_pre.xml EX-101.PRE 296550
Mailing Address 400 PROFESSIONAL DR, SUITE 400 GAITHERSBURG MD 20879
Business Address 400 PROFESSIONAL DR, SUITE 400 GAITHERSBURG MD 20879 240-631-3200
Emergent BioSolutions Inc. (Filer) CIK: 0001367644 (see all company filings)

IRS No.: 141902018 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-33137 | Film No.: 18807870
SIC: 2834 Pharmaceutical Preparations